Journalist Hunt

Journalists Pricing Blogs

Nick Slevin - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Nick Slevin's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today

Nick Slevin

Verified

Editor-in-Chief and Publisher, Peninsula Publishing, Builder and Developer

Newport Beach

Beats

Primary beats

Secondary beats

Investment Strategies Publishing Market Updates Neighborhood Guides Alcohol Pasadena NASA Polling Environment Los Angeles Market Update Religion and science Genetics

Final Covers

Housing, Finances , Self-Storage

Doesn’t Cover

Journalist Type

Print Journalist

Seniority Positions

Editor-in-Chief and Publisher

Industries

-

Medium Formats

Peninsula Publishing

Content

Total articles 1

Randomised phase III trial of the hypoxia modifier nimorazole added to radiotherapy with benefit assessed in hypoxic head and neck cancers determined using a gene signature (NIMRAD)
By David Thomson, Nick Slevin, Helen Baines, Guy Betts
Dec. 08, 2023
Randomised phase III trial of the hypoxia modifier nimorazole added to radiotherapy with benefit assessed in hypoxic head and neck cancers determined using a gene signature (NIMRAD)
By David Thomson, Nick Slevin, Helen Baines, Guy Betts
Dec. 08, 2023

As seen in

Greenhomebuilder,Residential Contractor,Builder And Developer,American Infrastructure,International Journal Of Radiation Oncology*Biology*Physics

Company Info

Builder and Developer

Irvine, California, United States

'+1 310-666-8288

Founded: